John Stone is named as a lobbyist on federal disclosure filings for 50 clients through Bgr Government Affairs. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Pharmacy, Food Industry (safety, labeling, etc.) and Taxation/Internal Revenue Code.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| STRYKER CORPORATION | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| RECESS | BGR GOVERNMENT AFFAIRS | Q3 2026 | Beverage Industry |
| BREAKTHROUGH T1D (F/K/A JDRF) | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| APPLIED BIOLOGICS | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| VAXCYTE, INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| PROLACTA BIOSCIENCE, INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| PTC THERAPEUTICS | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| BAYER CORPORATION | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| AMERICAN SOCIETY OF GENE AND CELL THERAPY | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| WALGREEN CO. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Pharmacy |
| EDWARDS LIFESCIENCES LLC | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| CARDINAL HEALTH | BGR GOVERNMENT AFFAIRS | Q3 2026 | Taxation/Internal Revenue Code, Trade (domestic/foreign), Health Issues |
| RAI SERVICES COMPANY | BGR GOVERNMENT AFFAIRS | Q3 2026 | Tobacco |
| NEUROCRINE BIOSCIENCES, INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Pharmacy |
| PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION | BGR GOVERNMENT AFFAIRS | Q3 2026 | Pharmacy |
| AMERICAN BEVERAGE ASSOCIATION | BGR GOVERNMENT AFFAIRS | Q3 2026 | Transportation, Agriculture, Health Issues |
| ADVANCED MEDICAL TECHNOLOGY ASSOCIATION | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| SENIOR CARE PHARMACY COALITION | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| BIOMARIN PHARMACEUTICAL INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| ALKERMES, INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| HEARTLAND FOOD PRODUCTS GROUP | BGR GOVERNMENT AFFAIRS | Q3 2026 | Food Industry (safety, labeling, etc.), Health Issues |
| NOVARTIS | BGR GOVERNMENT AFFAIRS | Q3 2026 | Medicare/Medicaid, Health Issues |
| FRESENIUS MEDICAL CARE NORTH AMERICA (FKA FRESENIUS MEDICAL CARE) | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| THE PROCTER & GAMBLE COMPANY | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| REGENERON PHARMACEUTICALS, INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| SARGENTO FOODS INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Food Industry (safety, labeling, etc.) |
| PFIZER, INC | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| AMGEN INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | BGR GOVERNMENT AFFAIRS | Q3 2026 | Pharmacy |
| GLAXOSMITHKLINE, INC | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| DEXCOM | BGR GOVERNMENT AFFAIRS | Q3 2026 | Medicare/Medicaid |
| ORCA BIO | BGR GOVERNMENT AFFAIRS | Q3 2026 | Medical/Disease Research/Clinical Labs |
| WK KELLOGG CO (FKA KELLOGG COMPANY) | BGR GOVERNMENT AFFAIRS | Q3 2026 | Food Industry (safety, labeling, etc.) |
| NUVATION BIO INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| UNILEVER | BGR GOVERNMENT AFFAIRS | Q3 2026 | Food Industry (safety, labeling, etc.), Taxation/Internal Revenue Code, Tariff (miscellaneous tariff bills) |
| DELCATH SYSTEMS, INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| FORS MARSH GROUP | BGR GOVERNMENT AFFAIRS | Q3 2026 | Government Issues |
| BECTON, DICKINSON AND COMPANY | BGR GOVERNMENT AFFAIRS | Q3 2026 | Tariff (miscellaneous tariff bills) |
| PEPSICO, INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Food Industry (safety, labeling, etc.) |
| ALLIANCE FOR REGENERATIVE MEDICINE | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| FAIRMOUNT FUNDS MANAGEMENT LLC | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| KRAFT HEINZ COMPANY | BGR GOVERNMENT AFFAIRS | Q2 2026 | Food Industry (safety, labeling, etc.), Taxation/Internal Revenue Code, Tariff (miscellaneous tariff bills) |
| ACCUMULUS SYNERGY, INC. | BGR GOVERNMENT AFFAIRS | Q4 2025 | Health Issues |
| GLOBAL KRATOM COALITION | BGR GOVERNMENT AFFAIRS | Q4 2025 | Health Issues |
| CHARLES RIVER LABORATORIES | BGR GOVERNMENT AFFAIRS | Q4 2025 | Animals, Pharmacy |
| EVERYONE MEDICINES | BGR GOVERNMENT AFFAIRS | Q3 2025 | Health Issues |
| DIGNITY AND WELLNESS PATIENT SOLUTIONS, LLC | BGR GOVERNMENT AFFAIRS | Q3 2025 | Health Issues |
| ABIOMED INC | BGR GOVERNMENT AFFAIRS | Q3 2025 | Health Issues |
| BIOMERIEUX, INC. | BGR GOVERNMENT AFFAIRS | Q1 2025 | Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 43 | 1 |
| 2025 | 40 | 1 |
| Year | Items | Total |
|---|---|---|
| 2026 | 23 | $26K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name John Stone. See the Capitol Clarity rankings and method.